Trials / Recruiting
RecruitingNCT03855722
Remote Ischaemic Preconditioning in Transplantation (RIPTRANS)
Remote Ischaemic Preconditioning in Transplantation (RIPTRANS) - A Prospective Randomized Controlled Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 496 (estimated)
- Sponsor
- Helsinki University Central Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Remote ischemic preconditioning (RIPC) is a concept where remotely induced ischemia produces protection against ischemia-reperfusion injury in a remote organ. RIPC has been studied extensively in animal models and heart surgery, but it's benefit in transplantation has been studied less. The primary aim of this study is to find out whether RIPC performed in a donor in donation after brain-death (DBD) could improve delayed graft function rate of kidney transplants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | RIPC | Remote Ischaemic Preconditioning |
| PROCEDURE | Sham-RIPC | Sham procedure |
Timeline
- Start date
- 2019-03-12
- Primary completion
- 2022-03-01
- Completion
- 2042-02-01
- First posted
- 2019-02-27
- Last updated
- 2020-03-10
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT03855722. Inclusion in this directory is not an endorsement.